Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia.

Lindström V, Aittoniemi J, Salmenniemi U, Käyhty H, Huhtala H, Sinisalo M.

Hum Vaccin Immunother. 2019 Jul 9:1-4. doi: 10.1080/21645515.2019.1627160. [Epub ahead of print]

PMID:
31216225
2.

Comparison of serological assays using pneumococcal proteins or polysaccharides for detection of Streptococcus pneumoniae infection in children with community-acquired pneumonia.

Borges IC, Andrade DC, Ekström N, Virta C, Melin M, Saukkoriipi A, Leinonen M, Ruuskanen O, Käyhty H, Nascimento-Carvalho CM.

J Immunol Methods. 2018 Sep;460:72-78. doi: 10.1016/j.jim.2018.06.011. Epub 2018 Jun 20.

PMID:
29935210
3.

Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage.

Andrade DC, Borges IC, Bouzas ML, Oliveira JR, Käyhty H, Ruuskanen O, Nascimento-Carvalho C.

Infect Dis (Lond). 2018 Sep;50(9):705-713. doi: 10.1080/23744235.2018.1463451. Epub 2018 Apr 24.

PMID:
29688138
4.

A toddler PCV booster dose following 3 infancy priming doses increases circulating serotype-specific IGG levels but does not increase protection against carriage.

Dagan R, Ben-Shimol S, Simell B, Greenberg D, Porat N, Käyhty H, Givon-Lavi N.

Vaccine. 2018 May 11;36(20):2774-2782. doi: 10.1016/j.vaccine.2018.04.007. Epub 2018 Apr 11.

PMID:
29655626
5.

Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.

Lindström V, Aittoniemi J, Salmenniemi U, Käyhty H, Huhtala H, Itälä-Remes M, Sinisalo M.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1471-1474. doi: 10.1080/21645515.2018.1436424. Epub 2018 Feb 23.

6.

Determination of avidity of IgG against protein antigens from Streptococcus pneumoniae: assay development and preliminary application in clinical settings.

Andrade DC, Borges IC, Ekström N, Jartti T, Puhakka T, Barral A, Kayhty H, Ruuskanen O, Nascimento-Carvalho CM.

Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):77-89. doi: 10.1007/s10096-017-3103-8. Epub 2017 Oct 12.

PMID:
29027028
7.

Infection by Streptococcus pneumoniae in children with or without radiologically confirmed pneumonia.

Andrade DC, Borges IC, Vilas-Boas AL, Fontoura MSH, Araújo-Neto CA, Andrade SC, Brim RV, Meinke A, Barral A, Ruuskanen O, Käyhty H, Nascimento-Carvalho CM.

J Pediatr (Rio J). 2018 Jan - Feb;94(1):23-30. doi: 10.1016/j.jped.2017.03.004. Epub 2017 Jun 29.

8.

Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery.

Hedberg AL, Pauksens K, Enblad P, Söderberg J, Johansson B, Käyhty H, Sjölin J.

Vaccine. 2017 Feb 7;35(6):909-915. doi: 10.1016/j.vaccine.2016.12.065. Epub 2017 Jan 6.

PMID:
28069358
9.

Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.

Borges IC, Andrade DC, Cardoso MR, Toppari J, Vähä-Mäkilä M, Ilonen J, Knip M, Hyöty H, Veijola R, Simell O, Jartti T, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM.

Clin Vaccine Immunol. 2016 Nov 4;23(11):878-883. Print 2016 Nov.

10.

Seasonal patterns and association of meteorological factors with infection caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in childhood community-acquired pneumonia in a tropical region.

Borges IC, Andrade DC, Cardoso MA, Meinke A, Barral A, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM.

Infect Dis (Lond). 2017 Feb;49(2):147-150. Epub 2016 Jul 27. No abstract available. Erratum in: Infect Dis (Lond). 2017 Feb;49(2):i.

PMID:
27464260
11.

Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.

Andrade DC, Borges IC, Adrian PV, Meinke A, Barral A, Ruuskanen O, Käyhty H, Nascimento-Carvalho CM.

Pediatr Infect Dis J. 2016 Jun;35(6):683-9. doi: 10.1097/INF.0000000000001126.

PMID:
26954601
12.

Serological diagnosis of pneumococcal infection in children with pneumonia using protein antigens: A study of cut-offs with positive and negative controls.

Andrade DC, Borges IC, Ivaska L, Peltola V, Meinke A, Barral A, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM.

J Immunol Methods. 2016 Jun;433:31-7. doi: 10.1016/j.jim.2016.02.021. Epub 2016 Feb 27.

PMID:
26928648
13.

Detection of antibody responses against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis proteins in children with community-acquired pneumonia: effects of combining pneumococcal antigens, pre-existing antibody levels, sampling interval, age, and duration of illness.

Borges IC, Andrade DC, Vilas-Boas AL, Fontoura MS, Laitinen H, Ekström N, Adrian PV, Meinke A, Cardoso MR, Barral A, Ruuskanen O, Käyhty H, Nascimento-Carvalho CM.

Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1551-7. doi: 10.1007/s10096-015-2385-y. Epub 2015 Apr 19.

PMID:
25894988
14.

Applied public health research on the frontline.

Palmu AA, Käyhty H.

Lancet Infect Dis. 2015 Apr;15(4):365-6. doi: 10.1016/S1473-3099(15)70052-6. Epub 2015 Feb 18. No abstract available.

PMID:
25701562
15.

Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults.

Hedberg AL, Pauksens K, Ronne-Engström E, Lundberg M, Johansson B, Käyhty H, Sjölin J.

J Infect. 2015 Jun;70(6):577-84. doi: 10.1016/j.jinf.2014.12.014. Epub 2015 Jan 3.

PMID:
25562448
16.

A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.

Andrade DC, Borges IC, Laitinen H, Ekström N, Adrian PV, Meinke A, Barral A, Nascimento-Carvalho CM, Käyhty H.

J Immunol Methods. 2014 Mar;405:130-43. doi: 10.1016/j.jim.2014.02.002. Epub 2014 Feb 11.

PMID:
24530690
17.

Pneumococcal conjugate vaccines (PCV). Foreword.

Käyhty H, O'Brien KL, Goldblatt D.

Vaccine. 2013 Dec 17;32(1):131-2. doi: 10.1016/j.vaccine.2013.05.066. No abstract available.

PMID:
24331111
18.

Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H; Pneumococcal Carriage Group (PneumoCarr).

Vaccine. 2013 Dec 17;32(1):153-8. doi: 10.1016/j.vaccine.2013.08.061. Epub 2013 Sep 7. Review.

PMID:
24016803
19.

Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.

Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H.

Vaccine. 2013 Dec 17;32(1):159-64. doi: 10.1016/j.vaccine.2013.06.105. Epub 2013 Jul 18. Review.

20.

Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy.

Ekström N, Ahman H, Palmu A, Grönholm S, Kilpi T, Käyhty H; FinOM Study Group.

Clin Vaccine Immunol. 2013 Jul;20(7):1034-40. doi: 10.1128/CVI.00039-13. Epub 2013 May 8.

21.

Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.

Ruuskanen O, Nurkka A, Helminen M, Viljanen MK, Käyhty H, Kainulainen L.

Clin Exp Immunol. 2013 May;172(2):238-44. doi: 10.1111/cei.12053.

22.

Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147).

Slayter KL, Singer J, Lee TC, Kayhty H, Schlech WF.

Int J STD AIDS. 2013 Mar;24(3):227-31. doi: 10.1177/0956462412472450. Epub 2013 May 6.

PMID:
23535358
23.

The fundamental link between pneumococcal carriage and disease.

Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL; Pneumococcal Carriage Group.

Expert Rev Vaccines. 2012 Jul;11(7):841-55. Review.

PMID:
22913260
24.

Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Ekström N, Givon-Lavi N, Käyhty H, Dagan R.

Clin Vaccine Immunol. 2012 Oct;19(10):1618-23. Epub 2012 Aug 8.

25.

Adenoidectomy in young children and serum IgG antibodies to pneumococcal surface protein A and choline binding protein A.

Mattila PS, Hammarén-Malmi S, Saxen H, Kaijalainen T, Käyhty H, Tarkkanen J.

Int J Pediatr Otorhinolaryngol. 2012 Nov;76(11):1569-74. doi: 10.1016/j.ijporl.2012.07.013. Epub 2012 Jul 24.

PMID:
22835927
26.

Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.

Olkinuora H, Käyhty H, Davidkin I, Roivainen M, Olander RM, Kantele JM, Siitonen S, Vettenranta K.

Acta Paediatr. 2012 Aug;101(8):e373-7. doi: 10.1111/j.1651-2227.2012.02710.x. Epub 2012 May 16.

PMID:
22537137
27.

Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.

Jounio U, Saukkoriipi A, Bratcher HB, Bloigu A, Juvonen R, Silvennoinen-Kassinen S, Peitso A, Harju T, Vainio O, Kuusi M, Maiden MC, Leinonen M, Käyhty H, Toropainen M.

J Clin Microbiol. 2012 Feb;50(2):264-73. doi: 10.1128/JCM.05385-11. Epub 2011 Nov 30.

28.

Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Lahdenkari M, Givon-Lavi N, Käyhty H, Dagan R, Jokinen J.

Clin Vaccine Immunol. 2012 Jan;19(1):96-9. doi: 10.1128/CVI.05369-11. Epub 2011 Nov 9.

29.

Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomy.

Mikoluc B, Motkowski R, Käyhty H, Heropolitanska-Pliszka E, Pietrucha B, Bernatowska E.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):805-9. doi: 10.1007/s10096-011-1378-8. Epub 2011 Aug 27.

30.

Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.

Holmlund E, Nohynek H, Quiambao B, Ollgren J, Käyhty H.

Vaccine. 2011 Jun 20;29(28):4565-75. doi: 10.1016/j.vaccine.2011.04.068. Epub 2011 May 6.

PMID:
21550374
31.

Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.

Simell B, Vuorela A, Ekström N, Palmu A, Reunanen A, Meri S, Käyhty H, Väkeväinen M.

Vaccine. 2011 Feb 24;29(10):1929-34. doi: 10.1016/j.vaccine.2010.12.121. Epub 2011 Jan 12.

PMID:
21236231
32.

Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.

Poolman J, Frasch C, Nurkka A, Käyhty H, Biemans R, Schuerman L.

Clin Vaccine Immunol. 2011 Feb;18(2):327-36. doi: 10.1128/CVI.00402-10. Epub 2010 Dec 1.

33.

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.

Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, Nahm MH, Ashton L, Haston M, Ekström N, Haikala R, Käyhty H, Henckaerts I, Durant N, Poolman JT, Fernsten P, Yu X, Hu BT, Jansen KU, Blake M, Simonetti ER, Hermans PW, Plikaytis BD.

Clin Vaccine Immunol. 2011 Jan;18(1):135-42. doi: 10.1128/CVI.00370-10. Epub 2010 Nov 17.

34.

Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae.

Melin M, Trzciński K, Antonio M, Meri S, Adegbola R, Kaijalainen T, Käyhty H, Väkeväinen M.

Infect Immun. 2010 Dec;78(12):5252-61. doi: 10.1128/IAI.00739-10. Epub 2010 Sep 20.

35.

The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.

Melin M, Trzciński K, Meri S, Käyhty H, Väkeväinen M.

Infect Immun. 2010 Dec;78(12):5262-70. doi: 10.1128/IAI.00740-10. Epub 2010 Sep 20.

36.

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants.

Madhi SA, Adrian P, Cotton MF, McIntyre JA, Jean-Philippe P, Meadows S, Nachman S, Käyhty H, Klugman KP, Violari A; Comprehensive International Program of Research on AIDS 4 Study Team.

J Infect Dis. 2010 Aug 15;202(3):355-61. doi: 10.1086/653704.

37.

Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination.

Väkeväinen M, Soininen A, Lucero M, Nohynek H, Auranen K, Mäkelä PH, Williams G, Käyhty H; ARIVAC Consortium.

J Pediatr. 2010 Nov;157(5):778-83.e1. doi: 10.1016/j.jpeds.2010.04.071. Epub 2010 Jun 14.

PMID:
20547399
38.

Adenoidectomy and nasopharyngeal carriage of Streptococcus pneumoniae in young children.

Mattila PS, Hammarén-Malmi S, Saxen H, Kaijalainen T, Käyhty H, Tarkkanen J.

Arch Dis Child. 2010 Sep;95(9):696-702. doi: 10.1136/adc.2009.165654. Epub 2010 May 26.

PMID:
20504840
39.

Interaction of pneumococcal histidine triad proteins with human complement.

Melin M, Di Paolo E, Tikkanen L, Jarva H, Neyt C, Käyhty H, Meri S, Poolman J, Väkeväinen M.

Infect Immun. 2010 May;78(5):2089-98. doi: 10.1128/IAI.00811-09. Epub 2010 Mar 1.

40.

Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.

Poolman JT, Frasch CE, Käyhty H, Lestrate P, Madhi SA, Henckaerts I.

Clin Vaccine Immunol. 2010 Jan;17(1):134-42. doi: 10.1128/CVI.00289-09. Epub 2009 Nov 4.

41.

Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children.

Simell B, Ahokas P, Lahdenkari M, Poolman J, Henckaerts I, Kilpi TM, Käyhty H.

Vaccine. 2009 Jul 23;27(34):4615-21. doi: 10.1016/j.vaccine.2009.05.071. Epub 2009 Jun 12.

PMID:
19524618
42.

IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H; ARIVAC Consortium.

Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24.

PMID:
19428879
43.

Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage.

Holmlund E, Quiambao B, Ollgren J, Jaakkola T, Neyt C, Poolman J, Nohynek H, Käyhty H.

Clin Vaccine Immunol. 2009 Jun;16(6):916-23. doi: 10.1128/CVI.00050-09. Epub 2009 Apr 29.

44.

Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination.

Madhi SA, Klugman KP, Kuwanda L, Cutland C, Käyhty H, Adrian P.

J Infect Dis. 2009 Apr 15;199(8):1168-76. doi: 10.1086/597388.

PMID:
19265481
45.

Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B.

Melin M, Jarva H, Siira L, Meri S, Käyhty H, Väkeväinen M.

Infect Immun. 2009 Feb;77(2):676-84. doi: 10.1128/IAI.01186-08. Epub 2008 Dec 1.

46.

Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Melin MM, Hollingshead SK, Briles DE, Lahdenkari MI, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1529-35. doi: 10.1128/CVI.00181-08. Epub 2008 Aug 27.

47.

Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, Kaijalainen T, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1555-63. doi: 10.1128/CVI.00177-08. Epub 2008 Aug 27.

48.

Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.

Pietrzyk JJ, Wysocki J, Pejcz J, Galaj A, Majda-Stanislawska E, Käyhty H, Thierry-Carstensen B, Jensen AM.

Vaccine. 2008 Sep 26;26(41):5296-303. doi: 10.1016/j.vaccine.2008.07.033. Epub 2008 Aug 27.

PMID:
18675870
49.

Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.

Toropainen M, Raitolehto A, Henckaerts I, Wauters D, Poolman J, Lestrate P, Käyhty H.

Infect Immun. 2008 Oct;76(10):4546-53. doi: 10.1128/IAI.00418-08. Epub 2008 Jul 21.

50.

Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins.

Simell B, Lahdenkari M, Reunanen A, Käyhty H, Väkeväinen M.

Clin Vaccine Immunol. 2008 Sep;15(9):1391-7. doi: 10.1128/CVI.00110-08. Epub 2008 Jul 2.

Supplemental Content

Loading ...
Support Center